Our review was based on a systematic PubMed search of randomized controlled trials (RCTs), observational studies, systematic reviews/meta-analyses, literature reviews, and case reports, published up to 2022, evaluating the combined treatment with a GLP-1RA and a SGLT2i in T2DM or prediabetes
Studies demonstrate that patients losing less than 5% body weight at early checkpoints rarely achieve clinically meaningful outcomes with continued treatment
Venkat, a Democrat, has introduced legislation to create a subscription model for GLP-1 drugs in which the state could enter value-based arrangements with drug manufacturers through supplemental rebate agreements
These drugs were originally developed for diabetes, then approved for weight loss, and are now being studied to see how they affect a variety of mental health disorders, including addiction and food noise, she explains